Jobs at 1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
About 1910
as of Sep 2026Multimodal AI Platform for Modality Agnostic Drug Discovery™
Funding
series-a · $40M · Oct 2024[web]
Investors: Microsoft's Venture Fund (M12), Accenture Ventures, FoundersX Ventures, Playground Global, OpenAI's Sam Altman, Y Combinator[web]
Recent news
- Oct 2024Accenture and 1910 collaborate on AI drug discovery[1]
- Jan 20261910 publishes PEGASUS, a multimodal AI model for macrocyclic peptides[2]
- Dec 20251910 publishes CANDID-CNS for blood-brain barrier prediction[3]
- Feb 2024Microsoft and 1910 partner on AI and high-performance computing for drug discovery[4]
[ Open roles ]
- Ai Research Scientist IRemote
As an AI Research Scientist I at 1910, you will contribute to drug discovery campaigns by applying AI/ML models. This role involves keeping up with scientific literature, prototyping methods, and acting as an individual contributor.
- Ai Research Scientist IiiRemote
AI Research Scientist III at 1910 is an individual contributor role focused on AI-native biotech drug discovery. The scientist will stay updated on literature, prototype methods, and apply AI/ML models to drug design campaigns.
- Computational Theoretical Chemist IiiRemote
Computational Theoretical Chemist III at 1910 in Boston, MA. This role focuses on leveraging computation, including AI and molecular dynamics simulation, to advance drug discovery. The position is part of an interdisciplinary team working on AI-enabled drug discovery for various disease areas.
- Computational Theoretical Chemist IRemote
Computational Theoretical Chemist I at 1910 in Boston, MA. This role is part of an AI-native biotech company focused on drug discovery. The position involves leveraging computational chemistry, AI, and molecular dynamics simulations to develop new therapeutics.
- Ai Research Scientist IiRemote
AI Research Scientist II at 1910, an AI-native biotech company. This role is an Individual Contributor focused on keeping up with scientific literature, prototyping methods, and applying AI/ML models to drug design campaigns.
- Computational Theoretical Chemist IiRemote
Computational Theoretical Chemist II at 1910 in Boston, MA. This role focuses on leveraging computation, AI, and molecular dynamics simulation to advance drug discovery, particularly for previously undruggable targets.